Nifedipine and Mortality
- 1 September 1995
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation
- Vol. 92 (5), 1068-1073
- https://doi.org/10.1161/01.cir.92.5.1068
Abstract
No abstract availableThis publication has 36 references indexed in Scilit:
- Platelet aggregability in vivo is attenuated byverapamil but not bymetoprolol in patients with stable angina pectorisThe American Journal of Cardiology, 1995
- Are all calcium antagonists equally effective for reducing reinfarction rate?The American Journal of Cardiology, 1993
- Hemorrhagic potential of combined diltiazem and recombinant tissue-type plasminogen activator administrationAmerican Heart Journal, 1993
- A proischaemic action of nisoldipine: relationship to a decrease in perfusion pressure and comparison to dipyridamoleCardiovascular Research, 1993
- Antihypertensive effect of felodipine associated with persistent sympathetic activation and minimal regression of left ventricular hypertrophyThe American Journal of Cardiology, 1992
- Meta-analysis in clinical trials reporting: Has a tool become a weapon?The American Journal of Cardiology, 1992
- “Cardioprotection” — Not all calcium antagonists are created equalThe American Journal of Cardiology, 1990
- Effect of verapamil on mortality and major events after acute myocardial infarction (The Danish Verapamil Infarction Trial II — DAVIT II)The American Journal of Cardiology, 1990
- Retardation of coronary artery disease in humans by the calcium-channel blocker nifedipine: Results of the INTACT study (International Nifedipine Trial on Antiatherosclerotic Therapy)Cardiovascular Drugs and Therapy, 1990
- Effects of Enalapril on Mortality in Severe Congestive Heart FailureNew England Journal of Medicine, 1987